Quoin Pharmaceuticals Ltd. (QNRX) reported a net loss of $5.37 million, or $1.90 per ADS basic and diluted, for the second quarter ended June 30, 2026. The company had approximately $10.8 million in cash, cash equivalents and marketable securities at quarter-end.
During the quarter, the FDA conditionally approved QYLEKI as the proposed brand name for QRX003 in Netherton Syndrome. Subsequent to quarter-end, the FDA cleared Quoin's IND for Peeling Skin Syndrome, supporting a planned Phase 2/3 study in the second half of 2026.
- Second-quarter net loss was $5.37 million, compared with $3.70 million a year earlier.
- Six-month net loss totaled $10.37 million, compared with $7.51 million in the prior-year period.
- FDA conditionally approved QYLEKI as QRX003's proposed brand name on June 23, 2026.
- The FDA cleared the Peeling Skin Syndrome IND on July 9, 2026.
- Quoin said its cash position is expected to fund operations into 2027.
$QNRX Hedge Fund Activity
We have seen 10 institutional investors add shares of $QNRX stock to their portfolio, and 9 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CENTIVA CAPITAL, LP removed 60,000 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $290,400
- ADAR1 CAPITAL MANAGEMENT, LLC removed 58,230 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $384,318
- VELAN CAPITAL INVESTMENT MANAGEMENT LP removed 52,477 shares (-61.8%) from their portfolio in Q2 2026, for an estimated $253,988
- CITADEL ADVISORS LLC added 32,519 shares (+inf%) to their portfolio in Q1 2026, for an estimated $214,625
- RESOLUTE CAPITAL ASSET PARTNERS LLC removed 30,000 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $198,000
- STONEPINE CAPITAL MANAGEMENT, LLC removed 24,729 shares (-31.6%) from their portfolio in Q1 2026, for an estimated $163,211
- BARCLAYS PLC added 20,169 shares (+1551.5%) to their portfolio in Q2 2026, for an estimated $97,617
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
